Last reviewed · How we verify

NCT04195048

Mechanism and Outcome of Acute Ischemic Stroke in Cancer Patients

Completed Last updated 11 December 2019
What this trial tests

trial testing Risk factors in Ischemic Stroke in 160 participants. Completed in 1 December 2019.

Timeline
1 November 2018
Primary endpoint
1 October 2019
1 December 2019

Quick facts

Lead sponsorMansoura University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment160
Start date1 November 2018
Primary completion1 October 2019
Estimated completion1 December 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University Hospital

Who can join

Adults 25 to 89, any sex, with Ischemic Stroke or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke is a part of circulatory diseases which are the primary cause of death in Egypt. It accounts 14% of all deaths thus ranks the 2nd after ischemic heart disease. Cancer accounts 9% of population mortality in Egypt. Nearly 108,600 Egyptians newly diagnosed with cancer each year. The interrelationship between stroke and cancer is complex. Cancer may directly or indirectly lead to stroke via: hypercoagulability, nonbacterial thrombotic endocarditis (NBTE), direct tumor compression of blood vessels or treatment-related effects which potentiate stroke. The risk of ischemic stroke after chemotherapy is largely increased by the use of certain types of chemotherapy not only by cancer histologic type. Brain infarction usually a subsequent complication appears sometimes shortly after chemotherapy. Chronic radiation vasculopathy that affects medium and large intra- and extra-cranial arteries is characterized by increasing rates of hemodynamic significant stenosis with time after radiotherapy. The study aims to clarify the relation between cancer and its treatment with ischemic stroke by discussing the different mechanisms by which a vascular insult happen causing neurological deficit. The study provides more information about cancer patients with higher risk to develop ischemic stroke more than other patients by identifying co morbidities and dosage of cancer treatment that causes cerebrovascular insults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Risk factors

Trials testing the same drug.

Other recruiting trials for Ischemic Stroke

Currently open trials in the same condition.

Other Mansoura University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04195048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing